Showing results (171-180 of 180) with videos related to
Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
Lung Cancer (Amsterdam, Netherlands)|June 30, 2024
BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLCMariano Provencio, Lucía Robado de Lope, Roberto Serna-Blasco, et al.JTO Clinical and Research Reports|March 25, 2024
RET Fusion Testing in Patients With NSCLC: The RETING StudyEsther Conde, Susana Hernandez, Jose Luis Rodriguez Carrillo, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 26, 2024
Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECPAylen Vanessa Ospina, Sergio Bolufer Nadal, José Luis Campo-Cañaveral de la Cruz, et al.JACC. Cardiooncology|January 11, 2024
Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art ReviewFadi N Salloum, Carlo G Tocchetti, Pietro Ameri, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2024
Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung CancerMelina Peressini, Rosario Garcia-Campelo, Bartomeu Massuti, et al.Translational Lung Cancer Research|October 24, 2025
Multidisciplinary approach for patients with early and locally advanced non-small cell lung cancer (NSCLC): 2nd Spanish Lung Cancer Group (GECP) expert consensus statementAylen Vanessa Ospina-Serrano, Jose Luis González-Larriba, Ernest Nadal, et al.Oncoimmunology|September 14, 2020
Tumor stem cells fuse with monocytes to form highly invasive tumor-hybrid cellsLuis Augusto Aguirre, Karla Montalbán-Hernández, José Avendaño-Ortiz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2025
Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B)James Chih-Hsin Yang, Mengzhao Wang, Ludovic Doucet, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 27, 2019
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma: the ROSING StudyEsther Conde, Susana Hernandez, Rebeca Martinez, et al.The Lancet. Oncology|January 31, 2012
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trialRafael Rosell, Enric Carcereny, Radj Gervais, et al.Pageof 18